Solmajer T - Search Results

1

Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents.

Pogorelčnik B, Perdih A, Solmajer T. Pogorelčnik B, et al. Among authors: solmajer t. Curr Med Chem. 2013;20(5):694-709. doi: 10.2174/092986713804999402. Curr Med Chem. 2013. PMID: 23210851 Review.

2

Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.

Smolnikar I, Perdih A, Stegnar M, Prezelj A, Solmajer T, Urleb U, Obreza A. Smolnikar I, et al. Among authors: solmajer t. Pharmazie. 2007 Apr;62(4):243-54. Pharmazie. 2007. PMID: 17484277

3

Distinct labelling of fusion events in rat lactotrophs by FM 1-43 and FM 4-64 is associated with conformational differences.

Stenovec M, Solmajer T, Perdih A, Vardjan N, Kreft M, Zorec R. Stenovec M, et al. Among authors: solmajer t. Acta Physiol (Oxf). 2007 Sep;191(1):35-42. doi: 10.1111/j.1748-1716.2007.01716.x. Epub 2007 Jun 5. Acta Physiol (Oxf). 2007. PMID: 17550407

4

Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.

Marinko P, Krbavcic A, Mlinsek G, Solmajer T, Bakija AT, Stegnar M, Stojan J, Kikelj D. Marinko P, et al. Among authors: solmajer t. Eur J Med Chem. 2004 Mar;39(3):257-65. doi: 10.1016/j.ejmech.2003.12.006. Eur J Med Chem. 2004. PMID: 15051174

5

In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors.

Oblak M, Grdadolnik SG, Kotnik M, Jerala R, Filipic M, Solmajer T. Oblak M, et al. Among authors: solmajer t. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5207-10. doi: 10.1016/j.bmcl.2005.08.068. Epub 2005 Oct 3. Bioorg Med Chem Lett. 2005. PMID: 16203145

6

Thrombin inhibitors built on an azaphenylalanine scaffold.

Zega A, Mlinsek G, Solmajer T, Trampus-Bakija A, Stegnar M, Urleb U. Zega A, et al. Among authors: solmajer t. Bioorg Med Chem Lett. 2004 Mar 22;14(6):1563-7. doi: 10.1016/j.bmcl.2003.12.083. Bioorg Med Chem Lett. 2004. PMID: 15006404

7

Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization.

Zega A, Mlinsek G, Sepic P, Golic Grdadolnik S, Solmajer T, Tschopp TB, Steiner B, Kikelj D, Urleb U. Zega A, et al. Among authors: solmajer t. Bioorg Med Chem. 2001 Oct;9(10):2745-56. doi: 10.1016/s0968-0896(01)00202-4. Bioorg Med Chem. 2001. PMID: 11557360

8

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.

Peterlin-Masic L, Mlinsek G, Solmajer T, Trampus-Bakija A, Stegnar M, Kikelj D. Peterlin-Masic L, et al. Among authors: solmajer t. Bioorg Med Chem Lett. 2003 Mar 10;13(5):789-94. doi: 10.1016/s0960-894x(03)00030-1. Bioorg Med Chem Lett. 2003. PMID: 12617892

9

Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics.

Peterlin-Masic L, Kranjc A, Marinko P, Mlinsek G, Solmajer T, Stegnar M, Kikelj D. Peterlin-Masic L, et al. Among authors: solmajer t. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3171-6. doi: 10.1016/s0960-894x(03)00717-0. Bioorg Med Chem Lett. 2003. PMID: 12951087

10

Characterization of quercetin binding site on DNA gyrase.

Plaper A, Golob M, Hafner I, Oblak M, Solmajer T, Jerala R. Plaper A, et al. Among authors: solmajer t. Biochem Biophys Res Commun. 2003 Jun 27;306(2):530-6. doi: 10.1016/s0006-291x(03)01006-4. Biochem Biophys Res Commun. 2003. PMID: 12804597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters